This topic contains a solution. Click here to go to the answer

Author Question: A client has an intraparenchymal probe inserted into his brain tissue. The nurse realizes an ... (Read 50 times)

Engineer

  • Hero Member
  • *****
  • Posts: 527
A client has an intraparenchymal probe inserted into his brain tissue. The nurse realizes an advantage of this type of intracranial monitoring device would be:
 
  1. low risk of intracerebral bleeding.
  2. low risk of infection.
  3. sturdy and will not break.
  4. an inexpensive method to monitor.

Question 2

The nurse measures a client's blood pressure to be 158/92 mmHg. The nurse recognizes that this blood pressure is classified as:
 
  1. normal.
  2. prehypertension.
  3. stage I hypertension.
  4. stage II hypertension.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

14vl19

  • Sr. Member
  • ****
  • Posts: 310
Answer to Question 1

2
The intraparenchymal probe is easy to insert and has a low risk of infection. The probe does have a risk of causing intracerebral bleeding. The catheter is fragile and may break. The equipment is expensive for this type of probe.

Answer to Question 2

3
Normal blood pressure is SBP less than 120 mmHg and DBP less than 80 mmHg. A prehypertensive state is SBP of 120 to 139 mmHg or DBP of 80 to 90 mmHg. Stage I hypertension is SBP of 140 to 159 mmHg or DBP of 90 to 99 mmHg. Stage II hypertension is a SBP of 160 mmHg or higher or a DBP of 100 mmHg or higher.




Engineer

  • Member
  • Posts: 527
Reply 2 on: Jun 25, 2018
Excellent


triiciiaa

  • Member
  • Posts: 349
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

More than 150,000 Americans killed by cardiovascular disease are younger than the age of 65 years.

Did you know?

Essential fatty acids have been shown to be effective against ulcers, asthma, dental cavities, and skin disorders such as acne.

Did you know?

About 100 new prescription or over-the-counter drugs come into the U.S. market every year.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

People with alcoholism are at a much greater risk of malnutrition than are other people and usually exhibit low levels of most vitamins (especially folic acid). This is because alcohol often takes the place of 50% of their daily intake of calories, with little nutritional value contained in it.

For a complete list of videos, visit our video library